SCN3B Gene Brugada Syndrome Type 7 NGS Genetic DNA Test
Comprehensive Genetic Testing for Inherited Cardiac Conditions
The SCN3B Gene Brugada Syndrome Type 7 NGS Genetic DNA Test represents a significant advancement in cardiac genetic diagnostics, offering precise detection of mutations associated with Brugada Syndrome Type 7. This specialized test provides critical insights into inherited cardiac conditions that can lead to sudden cardiac death, enabling early intervention and personalized treatment strategies.
What Does This Test Measure and Detect?
This comprehensive genetic analysis specifically targets the SCN3B gene, which encodes the sodium channel beta-3 subunit protein. The test utilizes Next-Generation Sequencing technology to identify:
- Pathogenic variants in the SCN3B gene associated with Brugada Syndrome Type 7
- Missense mutations affecting sodium channel function
- Genetic alterations that disrupt normal cardiac electrical activity
- Inherited mutations that increase risk of ventricular arrhythmias
- Specific nucleotide changes impacting sodium channel regulation
Who Should Consider This Genetic Test?
This test is particularly recommended for individuals experiencing:
- Unexplained syncope or fainting episodes
- Family history of sudden cardiac death or Brugada Syndrome
- Abnormal ECG patterns suggestive of Brugada Syndrome
- Recurrent palpitations or arrhythmias without clear cause
- First-degree relatives of diagnosed Brugada Syndrome patients
- Individuals with nocturnal agonal respiration
- Patients with documented ventricular fibrillation episodes
Key Benefits of SCN3B Genetic Testing
Undergoing this genetic analysis provides numerous advantages for cardiac health management:
- Early Risk Identification: Detect genetic predisposition before symptom onset
- Personalized Treatment Planning: Guide medication choices and intervention strategies
- Family Screening Guidance: Identify at-risk relatives for preventive care
- Improved Diagnostic Accuracy: Confirm clinical suspicions with genetic evidence
- Lifestyle Management: Implement appropriate activity restrictions and monitoring
- Peace of Mind: Reduce uncertainty about inherited cardiac risks
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert genetic counselors and cardiologists:
- Positive Result: Indicates presence of a pathogenic SCN3B mutation, requiring comprehensive cardiac evaluation and potential implantation of cardioverter-defibrillator
- Negative Result: Suggests absence of tested SCN3B mutations, though clinical follow-up may still be recommended based on symptoms
- Variant of Uncertain Significance: Requires additional family studies and periodic re-evaluation as genetic knowledge advances
- Carrier Status: Important for family planning and genetic counseling considerations
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our comprehensive network ensures accessible genetic testing services nationwide.
Take Control of Your Cardiac Health Today
Don’t wait to address potential inherited cardiac risks. Our specialized genetic testing provides the clarity needed for informed healthcare decisions. Schedule your SCN3B Gene Brugada Syndrome Type 7 NGS Genetic DNA Test today and take the first step toward comprehensive cardiac risk assessment.
Call or WhatsApp us now at +1(267) 388-9828 to book your appointment or request more information about this life-saving genetic test.
Our team of genetic counselors and cardiac specialists are ready to guide you through the testing process and help interpret your results within the context of your personal and family medical history.
